Platinum Investment Management’s Fulcrum Therapeutics FULC Stock Holding History

Platinum Investment Management’s Portfolio FULC Stock Details FULC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-152,186	Closed	-$4.29M	–	147
2021 Q3	$4.29M	Hold	152,186	–	–	0.12%	73
2021 Q2	$1.59M	Buy	152,186 +68,636	+82%	+$694K	0.04%	101
2021 Q1	$984K	Hold	83,550	–	–	0.02%	109
2020 Q4	$978K	Hold	83,550	–	–	0.02%	111
2020 Q3	$663K	Hold	83,550	–	–	0.02%	114
2020 Q2	$1.53M	Sell	83,550 -11,983	-13%	-$189K	0.03%	96
2020 Q1	$1.14M	Sell	95,533 -43,234	-31%	-$692K	0.03%	95
2019 Q4	$2.31M	Buy	138,767 +63,767	+85%	+$610K	0.05%	62
2019 Q3	$498K	Buy	+75,000	New	+$830K	0.01%	92

Other funds holding FULC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

TGI

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Platinum Investment Management's FULC Position: Q4 2021 in Review

Platinum Investment Management sold out of Fulcrum Therapeutics (FULC) in Q4 2021, closing a stake of 152,186 shares — an estimated $4.29M sold.

Platinum Investment Management first reported a position in FULC in Q3 2019 and held it in 9 quarters. The position peaked at $4.29M in Q3 2021. 110 funds tracked by Wall St. Rank hold FULC as of Q4 2021.

Platinum Investment Management reported no remaining Fulcrum Therapeutics position as of Q4 2021 after selling out during the quarter.
Platinum Investment Management sold 152,186 Fulcrum Therapeutics shares in Q4 2021, an estimated $4.29M.
Platinum Investment Management first reported a position in Fulcrum Therapeutics in Q3 2019 and held it in 9 quarters.
Platinum Investment Management's Fulcrum Therapeutics position peaked at $4.29M in Q3 2021.
110 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q4 2021.

Based on Platinum Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.